Cybin (HELP) Beginning Cash Balance (2020 - 2025)
Cybin (HELP) posted quarterly Beginning Cash Balance of $83.8 million for Q4 2025, down 26.74% year-on-year from $114.3 million in Q4 2024, and down 29.44% on a QoQ basis from $118.7 million in Q3 2025.
Cybin (HELP) Beginning Cash Balance (2020 - 2025) Analysis & Trends
Cybin (HELP) has reported Beginning Cash Balance for 6 consecutive years, with $83.8 million the latest figure, recorded in Q4 2025.
- Quarterly Beginning Cash Balance fell 26.74% year-over-year to $83.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $410.7 million (down 1.22% YoY) and the FY2023 annual result came in at $31.0 million, up 571.7% from the prior year.
- Beginning Cash Balance slipped to $83.8 million in Q4 2025 per HELP's latest filing, from $118.7 million in the prior quarter.
- Over the last five years, Beginning Cash Balance for HELP reached as high as $154.2 million in Q2 2024 and fell as low as -$9.6 million in Q1 2023.
- A 5-year average of $58.6 million and a median of $43.8 million in 2021 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2021 — Beginning Cash Balance surged 4574.57% — and 2023, when it sank 78.58%.
- Year by year, Beginning Cash Balance stood at $59.6 million in 2021, then sank by 63.02% to $22.1 million in 2022, then plunged by 39.66% to $13.3 million in 2023, then surged by 759.0% to $114.3 million in 2024, then dropped by 26.74% to $83.8 million in 2025.
- According to Business Quant data, Beginning Cash Balance over the past three periods registered $83.8 million, $118.7 million, and $93.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.75 Mn |
| Dec 31, 2025 | 83.75 Mn |
| Sep 30, 2025 | 118.69 Mn |
| Sep 30, 2025 | 118.69 Mn |
| Jun 30, 2025 | 93.92 Mn |
| Jun 30, 2025 | 93.92 Mn |
| Dec 31, 2024 | 114.32 Mn |
| Dec 31, 2024 | 114.32 Mn |
| Sep 30, 2024 | 133.90 Mn |
| Sep 30, 2024 | 133.90 Mn |
| Jun 30, 2024 | 154.24 Mn |
| Jun 30, 2024 | 154.24 Mn |
| Dec 31, 2023 | 13.31 Mn |
| Dec 31, 2023 | 13.31 Mn |
| Sep 30, 2023 | 6.97 Mn |
| Sep 30, 2023 | 6.97 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Feb 28, 2023 | -9.63 Mn |
| Feb 28, 2023 | -9.63 Mn |